NCT00349063

Brief Summary

The purpose of this study is to compare the wettability of contact lenses disinfected with three marketed contact lens care solutions.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2005

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

July 4, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 6, 2006

Completed
Last Updated

July 19, 2006

Status Verified

July 1, 2006

First QC Date

July 4, 2006

Last Update Submit

July 17, 2006

Conditions

Outcome Measures

Primary Outcomes (2)

  • To investigate the impact of wearing time and contact lens care solutions on in

  • vivo and ex vivo wettability of currently marketed contact lenses

Secondary Outcomes (3)

  • To determine if there is a correlation between in vivo wettability, ex vivo

  • wettability and in-eye comfort. To determine if comfort and wettability vary

  • between symptomatic and asymptomatic lens wearers.

Interventions

Eligibility Criteria

Age16 Years+
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Has had an oculo-visual examination in the last two years.
  • Is at least 18 years old and has full legal capacity to volunteer or is at least 16 years old, has a parent or guardian's permission to participate in the study and has read the Information and Consent Letter for adolescents.
  • \. Has read and understood the Information Consent Letter (Appendix II). 5. Is willing and able to follow participant instructions for product usage and meet the protocol-specified schedule of follow-up visits.
  • \. Has a refractive error that is correctable with the prescription of the available study lenses.
  • \. Has a refractive error that is correctable to at least 20/25 distance visual acuity with contact lenses in each eye.
  • \. Has acceptable fit with the study lenses. 9. Has clear corneas, and ocular clinical findings are considered "normal".

You may not qualify if:

  • Has any systemic disease that may affect ocular health.
  • Is using any systemic or topical medications that may affect ocular health.
  • Has any ocular pathology or severe insufficiency of lacrimal secretion (dry eyes) that may affect the wearing of contact lenses.
  • Has any clinically significant lid or conjunctival abnormalities, meibomian gland dysfunction, neovascularization, corneal scars or corneal opacities.
  • Has limbal injection, bulbar injection or corneal staining that, in the investigator's opinion, is clinically significant.
  • Has pinguecula and/or pterygium that, in the investigator's judgement, makes contact lens wear inadvisable.
  • Has refractive astigmatism of more than 0.75 D.
  • Has corneal distortion resulting from rigid lens wear.
  • Is aphakic.
  • Has undergone corneal refractive surgery.
  • Is participating in any other type of clinical or research study.
  • Is pregnant or lactating.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre for Contact Lens Research, University of Waterloo

Waterloo, Ontario, N2L 3G1, Canada

Location

MeSH Terms

Conditions

Refractive Errors

Interventions

Contact Lenses, Hydrophilic

Condition Hierarchy (Ancestors)

Eye Diseases

Intervention Hierarchy (Ancestors)

Contact LensesLensesOptical DevicesEquipment and Supplies

Study Officials

  • Craig Woods, PhD

    University of Waterloo

    PRINCIPAL INVESTIGATOR
  • Desmond Fonn, MOptom

    University of Waterloo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 4, 2006

First Posted

July 6, 2006

Study Start

July 1, 2005

Last Updated

July 19, 2006

Record last verified: 2006-07

Locations